Announcements Trials

Browse Landscape

Phase

Status

Terminated 2 Completed 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 2 Hematologic Neoplasms 2 Graft vs Host Disease 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Anemia, Aplastic 1

Interventions

Exercise 19 Drug Therapy 18 pembrolizumab 13 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 10 Radiotherapy 10 Paclitaxel 9 Dexamethasone 9 Nivolumab 8 Standard of Care 7 Oxaliplatin 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Control Groups 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Bevacizumab 5 sintilimab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × thymoglobulin × Clear all

NCT00750126 2011-01-19

RICE

University Hospital, Clermont-Ferrand

Phase 2 Unknown

Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡